12/23/2025CSPC Announces China Approval for Daratumumab Injection

12/23/2025Qilu Launches Phase 1 Trial of FIC CD3/CD20/CD79b Triple Antibody QLS2...

12/23/2025China Approves First Global CSF-1R Inhibitor Pimicotinib for Rare Join...

12/22/2025Alphamab's IND for PD-L1/VEGFR2 Bispecific ADC JSKN027 Accepted in Chi...

12/22/2025Epigenic Wins FDA IND Clearance for Novel Epigenetic Therapy Targeting...

12/18/2025Rona Advances Dual-Targeting siRNA RN5681 Into Clinical Development

12/18/2025HUTCHMED Initiates Global Clinical Development of FIC ATTC Candidate H...

12/18/2025China Grants First Global Approval to Cytokinetics' Cardiomyopathy Dru...

12/18/2025Atom Thera Advances Anti-Inflammatory Pipeline With FDA Clearance for ...

12/18/2025Sanofi's Aficamten Wins China Approval for Obstructive Hypertrophic Ca...

12/16/2025China Approves Genzyme's Fenthosilan Sodium Injection

12/16/2025InnoCare's Orelabrutinib Hits Primary Endpoint in Phase 2b Lupus Trial...

12/15/2025Qilu Advances GSPT1 Degrader ADC Program, PCT Patent Reveals

12/15/2025AusperBio Reports Promising Phase 2a Results for AHB-137 in Chronic He...

12/15/2025Qilu Wins Approval for China's First Fully Human Anti-EGFR Antibody

12/15/2025InnoCare Secures NMPA Approval for Pan-TRK Inhibitor Zurletrectinib

12/12/2025CMS's NDA for Innovative Stroke Drug Y-3 for Injection Accepted in Ch...

12/12/2025Ascletis' Acne Drug Denifanstat Enters NMPA Review After NDA Acceptanc...

12/12/2025InnoCare Pharma Wins NMPA Approval for Next-Gen TRK Inhibitor Zurletre...

12/11/2025China Approves Sanofi's Qfitlia (fitusiran) for Severe Hemophilia

12/11/2025Forward Pharma Reports Promising Early Data for Oral SERD FWD1802

12/11/2025Hengrui Launches Phase 1/2 Trial of Subcutaneous PD-1/VEGF BsAb SHR-46...

12/11/2025Kelingyuan Reports Early Tumor Responses for Novel HER2-Targeted ADC S...

12/11/2025China Approves Boehringer Ingelheim's Jascayd for Progressive Pulmonar...

12/10/2025Dizal Showcases Broad ASH25 Data for Golidocitinib and Birelentinib

12/10/2025InnoCare Highlights Strong ASH25 Data for BCL2 Inhibitor Mesutoclax

12/10/2025Lepu Reports Encouraging Phase II Results for CD20-Targeted ADC Combo

12/9/2025Ascletis Reports Positive Phase II Results for Oral GLP-1 Agonist ASC3...

12/9/2025Biokin Reports Strong Phase 2 Results for HER2-Targeted ADC T-Bren

12/8/2025Pfizer Files for Approval of Zavegepant Nasal Spray in China

Page:1/21 Total number of articles:605: [First][<<] [1] [2] [3] [4] [5] [>>] [End]